ILD & Early Rheumatoid Arthritis

Trial Objective

ILD and Early Rheumatoid ArthritisThe purpose of this study is to learn how interstitial lung disease (ILD) develops and progresses over time in people with early rheumatoid arthritis (RA). There is evidence that RA starts in the lungs in a subset of patients and through this study researchers will be looking at the relationship between your RA and your lungs.


New enrollment for this trial is temporarily paused

Who Can Participate

Adults diagnosed with rheumatoid arthritis within the last two years may be eligible to participate.

Age: 18-90    Gender: Any Gender

Estimated Time Commitment

5 in-person visits over 18 months

Payment & Reimbursement  

Payment: Not Provided

Travel Reimbursement: Not Available

Trial Contact

For more information, contact:

Faduma Ahmed, Trial Coordinator

Faduma Ahmed

Request More Information

Trial Location

National Jewish Main Campus, Denver, CO

Trial Sponsors

Boehringer Ingelheim


Request More Information

After limiting clinical research activity due to safety concerns about COVID-19, we are now restarting clinical research in stages. If you are interested in any of the clinical trials posted on our website, please request trial information. We will respond and share the timing for enrollment resuming. Learn More